Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114930513 | 11493051 | 3 | F | 20160712 | 20150911 | 20160719 | EXP | CA-AMGEN-CANSP2015093019 | AMGEN | 41.00 | YR | A | M | Y | 0.00000 | 20160718 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114930513 | 11493051 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 114930513 | 11493051 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 114930513 | 11493051 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 114930513 | 11493051 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 114930513 | 11493051 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 114930513 | 11493051 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 114930513 | 11493051 | 7 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | 0 | ||||||||||
| 114930513 | 11493051 | 8 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114930513 | 11493051 | 1 | Rheumatoid arthritis |
| 114930513 | 11493051 | 2 | Rheumatoid arthritis |
| 114930513 | 11493051 | 3 | Rheumatoid arthritis |
| 114930513 | 11493051 | 4 | Rheumatoid arthritis |
| 114930513 | 11493051 | 5 | Rheumatoid arthritis |
| 114930513 | 11493051 | 6 | Rheumatoid arthritis |
| 114930513 | 11493051 | 7 | Rheumatoid arthritis |
| 114930513 | 11493051 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114930513 | 11493051 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114930513 | 11493051 | Activities of daily living impaired | |
| 114930513 | 11493051 | Condition aggravated | |
| 114930513 | 11493051 | Drug effect decreased | |
| 114930513 | 11493051 | Drug ineffective | |
| 114930513 | 11493051 | Fatigue | |
| 114930513 | 11493051 | Hepatic enzyme abnormal | |
| 114930513 | 11493051 | Local swelling | |
| 114930513 | 11493051 | Migraine | |
| 114930513 | 11493051 | Neck pain | |
| 114930513 | 11493051 | Nodule | |
| 114930513 | 11493051 | Pain | |
| 114930513 | 11493051 | Pain in extremity | |
| 114930513 | 11493051 | Peripheral swelling | |
| 114930513 | 11493051 | Rheumatoid arthritis | |
| 114930513 | 11493051 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114930513 | 11493051 | 1 | 2012 | 0 | ||
| 114930513 | 11493051 | 4 | 2015 | 0 |